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Background-—Genome-wide association studies have shown an association between the single-nucleotide polymorphism
rs17514846 on chromosome 15q26.1 and coronary artery disease susceptibility. The underlying biological mechanism is, however,
not fully understood. rs17514846 is located in the FESUpstream Region (FURIN) gene, which is expressed in vascular endothelial cells
(ECs). We investigated whether rs17514846 has an influence on FURIN expression in ECs and whether FURIN affects EC behavior.
Methods and Results-—Quantitative reverse transcription–polymerase chain reaction analysis showed that cultured vascular ECs
from individuals carrying the coronary artery disease risk allele of rs17514846 had higher FURIN expression than cells from
noncarriers. In support, luciferase reporter analyses in ECs indicated that the risk allele had higher transcriptional activity than the
nonrisk allele. Electrophoretic mobility shift assays using EC nuclear protein extracts detected a DNA-protein complex with allele-
specific differential binding of a nuclear protein. Knockdown of FURIN in ECs reduced endothelin-1 secretion, nuclear factor-jB
activity, vascular cell adhesion molecule-1, and MCP1 (monocyte chemotactic protein-1) expression and monocyte-endothelial
adhesion and transmigration. A population-based study showed an association of the rs17514846 risk allele with higher circulating
MCP1 levels and greater carotid intima-media thickness.
Conclusions-—The coronary artery disease risk variant at the 15q26.1 locus modulates FURIN expression in vascular ECs. FURIN levels in
ECs affect monocyte-endothelial adhesion and migration. ( J Am Heart Assoc. 2020;9:e014333. DOI: 10.1161/JAHA.119.014333.)
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G enome-wide association studies have identified a coro-nary artery disease (CAD) susceptibility locus on
chromosome 15q26.1.1–3 At this locus, the A allele of the
lead single-nucleotide polymorphism (SNP) rs17514846,
located in the FES Upstream Region (FURIN) gene, is
associated with increased CAD risk.1–3 The biological mech-
anism underlying this genetic association, however, is still not
fully understood and warrants further investigation.
The FURIN gene encodes the subtilisin-like proprotein
convertase FURIN, which possesses proteolytic activity
to cleave the prodomain off of, and thereby activates, certain
proteins. Endothelial cells (ECs), monocytes/macrophages,
and smooth muscle cells in human atherosclerotic plaques
express FURIN.4 Animal studies have demonstrated that
FURIN promotes atherogenesis.5
Our recent study shows that rs17514846 modulates FURIN
expression in monocytes and that levels of FURIN in
monocytes affect their migratory and proliferative ability,6
which may partly explain the association of rs17514846 with
CAD risk.
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Because ECs in atherosclerotic plaques also express
FURIN4 and because ECs also play a vital role in atheroge-
nesis, we sought, in the present study, to determine whether
rs17514846 has an effect on FURIN expression in ECs and
investigate the effect of altered FURIN expression on EC
functional behavior, with a goal to gain a more complete
understanding of the biological mechanism underpinning the
genetic association with CAD risk.
Methods
The data that support the findings of this study are available
from the corresponding author on reasonable request.
Bioinformatics Analysis
Bioinformatics analysis of the genomic region containing
rs17514846 was performed. Histone modification and tran-
scription-level data at the rs17514846 site in human vascular
ECs, reported by Encyclopedia of DNA Elements, were
obtained using the University of California, Santa Cruz,
Genome Browser (https://genome.ucsc.edu/).
Isolation of Vascular ECs
This study had ethical approval from Queen Mary, University
of London (reference: 08/H0704/140). All human tissue
samples were fully anonymized before distribution to the
recipient analysis groups, as per ethical approval. Venous ECs
were isolated from umbilical cords from different individuals
using the collagenase digestion method, as previously
described.7
Cell Culture
Human umbilical vein ECs (HUVECs) were cultured in M199
media with supplementation, as described previously.8 THP1
monocytic cells were maintained in RPMI-1640 media,
supplemented with 10% (v/v) fetal bovine serum, 100 U/mL
penicillin, and 100 lg/mL streptomycin. All cells were
cultured in a humidified incubator at 37°C with 5% CO2.
Genotyping
Genomic DNA, extracted from cultured HUVECs of different
individuals and from blood samples of Bruneck Study
participants, was genotyped for rs17514846 using a TaqMan
SNP genotyping assay (C___1244341_10; Applied Biosys-
tems).
Reverse Transcription–Polymerase Chain
Reaction
RNA samples, prepared from cultured HUVECs from different
individuals, were reverse transcribed using random primers
(Promega) and M-MLV reverse transcriptase (Promega). The
resulting cDNA was subjected to real-time polymerase chain
reaction for FURIN and the housekeeping gene 18S rRNA,
using TaqMan gene expression assays (Hs00965485_g1 and
Hs99999901_s1; Applied Biosystems).
Luciferase Reporter Assay
Two sets of plasmid constructs containing a firefly luciferase
reporter gene were generated using the pGL4.10-promoter
vector (Promega). One set of these constructs contained an
inserted DNA sequence from nucleotide position chromo-
some 15:90873290 to chromosome 15:90873350 on the
hg38 human reference sequence, with either the A or C
allele at the rs17514846 site (chromosome 15:90873320).
The other set of constructs contained 3 tandemly repeated
copies of the sequence from chromosome 15:90873309 to
chromosome 15:90873331, with either the A or C allele at
rs17514846. These constructs were individually combined
with a Renilla luciferase reference plasmid (pRL-TK;
Promega) and transfected into HUVECs (ATCC; CRL2480).
After 48 hours, luciferase assays using the Dual-Glo
Luciferase Assay System (Promega) were performed.
Firefly luciferase data were normalized to Renilla to
determine the relative activity of the cloned DNA
sequences.
Clinical Perspective
What Is New?
• The coronary artery disease–associated single-nucleotide
polymorphism rs17514846 on chromosome 15q26.1 exerts
an allele-specific effect on FURIN expression in vascular
endothelial cells.
• The level of FURIN in vascular endothelial cells has an
influence on monocyte-endothelial adhesion and transmi-
gration, mediated by an effect of FURIN on the secretion of
endothelin-1, nuclear factor-jB activity, and the expression
of vascular cell adhesion molecule-1 and MCP1 (monocyte
chemotactic protein-1).
• Individuals carrying the rs17514846 risk allele have higher
circulating MCP1 levels and greater carotid intima-media
thickness.
What Are the Clinical Implications?
• The results of this study provide new evidence supporting a
role of FURIN in the pathogenesis of atherosclerosis and
indicating FURIN as a potential therapeutic target for
atherosclerosis.
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Electrophoretic Mobility Shift Assay
Nuclear protein extracts from HUVECs (ATCC; CRL2480) were
prepared using the NE-PER Nuclear and Cytoplasmic Extrac-
tion Reagents (ThermoFisher Scientific), according to the
manufacturer’s protocol. Fluorescein amidite-labeled, double-
stranded DNA probes corresponding to the sequence (hg38
human reference sequence: chromosome 15:90873308 to
chromosome 15:90873332) encompassing the rs17514846
site (chromosome 15:90873320) with either the A or C at this
position, were individually incubated with EC nuclear protein
extracts, in the presence or absence of unlabeled C or A allele
oligonucleotides and an unlabeled unrelated oligonucleotide,
respectively. The mixes were subjected to 10% nondenaturing
polyacrylamide gel electrophoresis, and free probes and
probe-protein complexes were detected using the LightShift
Chemiluminescent EMSA kit (Pierce Biotechnology; 20148).
Three independent experiments were performed.
FURIN siRNA and Transfection
HUVECs (ATCC; CRL2480) from a donor of the A/C genotype
for rs17514846 at passage 5 were transfected with either a
FURIN siRNA (ThermoFisher Scientific; s9988) or a control
siRNA (ThermoFisher Scientific; 4390843) using Lipofec-
tamine RNAiMAX transfection reagent (Invitrogen). FURIN
knockdown was verified by Western blot.
Monocyte-Endothelial Adhesion Assay
Peripheral blood–derived primary monocytes, isolated using
Dynabeads FlowComp Human CD14 kit (ThermoFisher Scien-
tific; 11367D), were stained with CellTracker Green CMFDA
Dye (ThermoFisher Scientific; C7025). Labeled monocytes
(19105 cells per well in 96-well plates) were then incubated
with a monolayer of untreated and siRNA-transfected HUVECs
for 1 hour, followed by washing to remove nonadhered
monocytes, fixation, and fluorescencemicroscopy. The number
of adhered monocytes was counted using ImageJ software.
Monocyte-Endothelial Transmigration Assay
A total of 59103 HUVECs (ATCC; CRL2480) of the A/C
genotype for rs17514846 were seeded in 4.26-mm diameter
transwells with a 5.0-lm pore size (Corning Costar; 3388)
and transfected the next day (at 60%–80% confluence) with
either a FURIN siRNA or a control siRNA and cultured for
48 hours to produce a confluent monolayer. Nontransfected
controls were also included in all experiments. For transmi-
gration assays, peripheral blood–derived primary monocytes
or THP1 monocytes were stained with 2.5 mmol/L Cell-
Tracker Green CMFDA Dye (ThermoFisher Scientific; C7025)
in serum-free RPMI-1640 medium for 30 minutes at 37°C.
Monocytes were then washed with serum-free RPMI-1640
medium before being added to the transwell (19105 cells
per transwell in 100-lL media). Migration was allowed to
proceed for 4 hours at 37°C. After 4 hours, the transwell
insert was removed and transmigration of monocytes was
assessed by counting the number of cells that had migrated
through the membrane.
Western Blot Analysis
Protein lysates of HUVECs were prepared using Radio Immuno
Precipitation Assay (RIPA) Lysis Buffer. Western blot analysis
was performed using antibodies against FURIN (Abcam;
ab183495), endothelin-1 (Abcam; ab117757), vascular cell
adhesion molecule-1 (VCAM1) (Abcam; ab174279), MCP1
(monocyte chemotactic protein-1) (Abcam; ab151538), and
beta-Actin (Sangon Biotech; D110001).
Quantification of Endothelin-1 by ELISA
The levels of endothelin-1 in the supernatants of HUVEC
cultures were measured using an ELISA kit (R&D Systems;
QET00B) and a TECAN Infinite M200 Pro plate reader.
Quantification of each sample was performed using a
standard curve of known concentrations.
Nuclear Factor jB p65 Transcription Factor
Activity Assay
HUVEC nuclear extracts were prepared using the NE-PER
Nuclear and Cytoplasmic Extraction Reagents (ThermoFisher
Scientific; 78833). Nuclear factor (NF) jB activity was
determined using 9 lg of nuclear extract and an NFjB p65
Transcription Factor Assay Kit (Abcam; ab133112), following
the manufacturer’s instructions. Absorbance was measured at
450 nm with a TECAN Infinite M200 Pro plate reader.
Bruneck Study Cohort and Measurements of
Plasma MCP1 Levels and Carotid Intima-Media
Thickness
The Bruneck Study is a population-based study of atheroscle-
rosis.9–12 Recruitment and characteristics of the Bruneck Study
cohort have been described previously.9–12 The study protocol
was approved by the appropriate ethics committees, and all
study subjects gave written informed consent before entering
the study. At the outset of the study in 1990, a sex- and age-
stratified random sample of all inhabitants of Bruneck (Bolzano
Province, Italy), aged 40 to 79 years (125 women and 125 men
in each of the fifth to eighth decade; total n=1000), was drawn
and the individuals were invited to take part in the study. A total
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of 93.6% participated, and data collection was completed for
919 subjects. The cohort was followed up in 1995, 2000, and
2005. DNA was extracted from blood samples taken from
individuals (n=826) who took part in the 1995 follow-up, and
used in the present study for genotyping rs17514846. Plasma
MCP1 levels in samples taken in 2000 were determined by
proximity extension assay13 using ProseekMultiplex CVD I96996
reagents kits (Olink Bioscience, Sweden). Common carotid
intima-media thickness was determined by Doppler ultrasound
examination in 1995, as described previously.9,10
Statistical Analyses
Statistical analyses were undertaken using SPSS software.
Reverse transcription–polymerase chain reaction Ct (cycle
threshold)values of FURIN were standardized against 18S rRNA
Ct values, using the DCt method.
14 Standardized FURIN Ct
values were normalized by log transformation, and then a linear
regression analysis was performed to test for an association
between genotype (with C/C, C/A, and A/A coded as 0, 1, and
2, respectively) and log-transformed standardized FURIN values
under an additive genetic model, whereas a t test was performed
to ascertain an effect of genotype (with C/C coded as 1 and
both C/A and A/A coded as 2) on log-transformed standardized
FURIN values under an A-allele dominant model. The Mann-
Whitney test was used to ascertain differences between C and A
alleles in luciferase activity in the luciferase reporter assays and
differences between control siRNA transfected cells versus
FURIN siRNA transfected cells in the intensity of Western blot
bands of FURIN, endothelin-1, VCAM1, and MCP1, endothelin-1
concentration in EC culture supernatants, NFjB activity,
monocyte-endothelial adhesion, and monocyte-endothelial
transmigration. Values of blood MCP1 levels in the Bruneck
Study subjects were normalized by log transformation, and a
linear regression analysis was then performed to test an
association between genotype (with C/C, C/A, and A/A coded
as 0, 1, and 2, respectively) in log-transformed MCP1 levels
under an additive genetic model, whereas a general linear model
analysis was performed to ascertain an effect of genotype (with
C/C coded as 1 and both C/A and A/A coded as 2) on log-
transformed MCP1 levels under an A-allele dominant model,
with adjustment for age and sex in both additive and dominant
models. A linear regression analysis was performed to test an
association between genotype and carotid intima-media thick-
ness in Bruneck Study participants with adjustment for age and
sex. All P values were 2 sided.
Results
rs17514846 Influences FURIN Expression in ECs
A bioinformatics analysis showed that rs17514846 was
located in a genomic region with active transcription in ECs
(Figure 1). To determine if there was an allelic/genotypic
effect of rs17514846 on FURIN expression in ECs, we
genotyped a collection of ECs from different individuals
(n=131) for rs17514846 and performed reverse transcription–
polymerase chain reaction analysis to quantify FURIN expres-
sion levels in the cells. The analysis showed an association
between rs17514846 genotype and FURIN expression levels
in ECs, with the A allele associating with higher FURIN
expression (Figure 2).
Having detected an association between rs17514846
genotype and FURIN expression in ECs, we investigated
Figure 1. Results of bioinformatics analysis of the genomic region containing rs17514846. The figure was generated from University of
California, Santa Cruz, Genome Browser (https://genome.ucsc.edu) with data from the Encyclopedia of DNA Elements Project showing features
of active transcription, including histone modification marks (H3K27Ac, H3K4Me1, and H3K4Me3) and transcription level at the rs17514846
site, in human vascular endothelial cells.
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whether rs17514846 can directly modulate gene expression
using a luciferase reporter assay. Cultured ECs were trans-
fected with a firefly luciferase reporter plasmid containing
either the A or C alleles of rs17514846, together with a Renilla
luciferase plasmid to serve as a transfection efficiency
control. This assay showed that cells transfected with the A
allele plasmid had significantly higher firefly luciferase levels
than C allele plasmid transfectants (Figure 3), suggesting that
the A allele has greater strength in driving gene expression
than the C allele.
In addition, an electrophoretic mobility shift assay using EC
nuclear protein extracts was performed to investigate if there
was a difference between the 2 alleles of rs17514846 in
nuclear protein binding. We found preferential nuclear protein
binding to the labeled C allele probe compared with the
labeled A allele probe (lanes 2 and 9, respectively; Figure 4).
Moreover, the DNA-protein complex was hardly detected in
the presence of the unlabeled C allele probe as a competitor
in 209 molar excess (lane 4; Figure 4). However, it was still
readily detectable in the presence of the unlabeled A allele
probe (lane 6; Figure 4). These data indicate that the C allele
has greater affinity for binding of nuclear proteins compared
with the A allele.
FURIN Promotes Monocyte-Endothelial Adhesion
and Transmigration
We previously demonstrated that monocyte FURIN levels
influenced the ability of monocytes to migrate through a
polycarbonate membrane (with 8-lm pores) in a transwell
assay.6 In the present study, we further investigated whether
Figure 2. Influence of rs17514846 genotype on FURIN expres-
sion in vascular endothelial cells. Primary cultures of human
vascular endothelial cells from different individuals were geno-
typed for rs17514846 and subjected to quantitative reverse
transcription–polymerase chain reaction analysis of FURIN. The
graph shows mean and SE values of FURIN expression levels in
each rs17514846 genotype group, after normalization to the 18S
rRNA gene and the C/C group.
Figure 3. Effects of rs17514846 on gene transcription regulation. Luciferase reporter assays were
performed by transfecting vascular endothelial cells with luciferase plasmids containing 60 bp of DNA
encompassing rs17514846 (left) or with luciferase plasmids containing 3, 22-bp repeats containing
rs17514846 (right). Both assays included Renilla luciferase as a transfection efficiency control. Columns
and error bars represent mean (normalized to the C allele data) and SE values, respectively. N=3
experiments.
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the level of FURIN in ECs had an effect onmonocyte-endothelial
adhesion and monocyte transendothelial migration. Adhesion
assays and migration assays using blood-derived primary
monocytes showed that siRNA-mediated FURIN knockdown in
ECs (Figure 5A) inhibited monocyte adhesion to ECs (Fig-
ure 5B) and retarded monocyte transendothelial migration
(Figure 5C). Migration assays using THP1 monocytes also
showed a trend toward reduced transendothelial migration
when FURIN was knocked down in ECs (Figure 5D).
FURIN Influences Endothelin-1 Secretion, NFjB
Activity, and Expression of VCAM1 and MCP1
To investigate possible reasons for the observed inhibitory
effect of FURIN knockdown on monocyte-endothelial adhe-
sion and transmigration, we first tested whether FURIN
knockdown affected endothelin-1 secretion because a previ-
ous study showed that in mice, EC-specific knockout of FURIN
resulted in a substantial decrease in mature endothelin-1.15
We found that knockdown of FURIN in cultured human ECs
resulted in no change in cytoplasmic endothelin-1 (Figure 6A)
but led to a reduction in secreted endothelin-1 (Figure 6B),
suggesting a role of FURIN on endothelin-1 processing and
secretion in human ECs.
Having confirmed that FURIN played a role in endothelin-1
secretion, we tested whether FURIN had an effect on the
activity of the transcription factor NFjB in ECs, as previous
studies showed that endothelin-1 induced NFjB activation in
cancer cells.16,17 Our study demonstrated that FURIN knock-
down in cultured ECs resulted in reduced NFjB activity
(Figure 6C), indicating a role of FURIN in NFjB activity
regulation in ECs.
Because NFjB plays a critical role in the expression of
VCAM118 and MCP1,19 which are key mediators of monocyte-
endothelial adhesion and transmigration,20 we investigated
whether FURIN had an effect on VCAM1 and MCP1 expres-
sion. We found that FURIN knockdown resulted in decreased
expression of VCAM1 and MCP1 in ECs (Figure 6D and 6E),
which is likely to account for, at least in part, the effect of
FURIN on monocyte-endothelial adhesion and transmigration.
Furthermore, we found that there was an association
between the A allele of SNP rs17514846 and higher circulating
MCP1 levels in a cohort of individuals who participated in a
population-based study of atherosclerosis, the Bruneck
Study9–12 (Figure 7). We did not detect an association between
rs17514846 genotype and the level of circulating VCAM1,
intercellular adhesion molecule 1, E-selection, or P-selectin in
the Bruneck Study cohort.
Figure 4. Allele-specific effect of rs17514846 on nuclear protein binding. Fluorescence-labeled double-
stranded 25-mer oligonucleotide probes corresponding to the sequence encompassing the rs17514846
site, with either C or A at the rs17514846 site, were individually incubated with or without vascular
endothelial cell nuclear protein extracts, in the presence or absence of unlabeled C allele oligonucleotide,
unlabeled A allele oligonucleotide, or an unrelated oligonucleotide, respectively, followed by nondena-
turing PAGE and fluorescence detection of the labeled probes. Arrows indicate a DNA-protein complex
and the free probe. Image shown is a representative from 3 experiments.
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rs17514846 Is Associated With Carotid
Intima-Media Thickness
Further to the findings described above, we investigated if
there was an association between rs17514846 genotype and
carotid intima-media thickness, a well-established biomarker
of early atherosclerosis and a predictor of future cardiovas-
cular events.21,22 An analysis of individuals participating in the
Bruneck Study showed an association between the A allele of
rs17514846 and greater carotid intima-media thickness
(Table), which remained significant after adjusting for age
and sex.
Discussion
It has been shown that in human atherosclerotic plaques, ECs
express FURIN.4 A key new finding of our present study is that
the CAD-associated SNP rs17514846 at the 15q26.1 locus
modulates the expression of FURIN in ECs, with the CAD risk
(A) allele having higher FURIN expression levels than the
nonrisk (C) allele. This complements our previously reported
observation that rs17514846 genotype affects FURIN expres-
sion in monocytes,6 indicating that the CAD-associated
variant exerts a regulatory effect on FURIN expression in
both cell types that are known to play pivotal roles in the
Figure 5. FURIN in vascular endothelial cells affects monocyte-endothelial adhesion and transmigration.
A, Western blot analysis of untreated and siRNA-transfected endothelial cells at 72 hours after transfection
was used to confirm successful knockdown of FURIN. A representative Western blot image is shown. Band
intensities were normalized to b-actin, N=9 per group. B, Results of monocyte-endothelial adhesion assay.
Peripheral blood–derived primary monocytes were stained with CellTracker Green CMFDA and then
incubated with a monolayer of untreated and siRNA-transfected endothelial cells for 1 hour, followed by
washing to remove nonadhered THP1 cells, fixation, and fluorescence microscopy. The number of adhered
THP1 cells was counted using ImageJ software. N=5 per group. C and D, Result of monocyte-endothelial
transmigration assay. Peripheral blood–derived primary monocytes (C) or THP1 monocytes (D) were stained
with CellTracker Green CMFDA and then incubated with a confluent monolayer of untreated and siRNA-
transfected endothelial cells cultured on 96-well transwells. After 4 hours, the number of THP1 cells that
had migrated into the lower chamber was counted. N=8 per group (C), and N=6 per group (D). A through D,
Graphs show mean values normalized to untreated samples, and error bars show SE.
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development and progression of atherosclerosis.20,23 The
rs17514846 resides in intron 1 of the FURIN gene and is
located in a genomic region with enriched binding of
transcription factors, as indicated by histone 3 lysine 27
acetylation marks (Figure 1). Electrophoretic mobility shift
assays, performed as part of our study, indicated that
rs17514846 has an allele-specific effect on the binding of a
nuclear protein present in vascular ECs, which might possibly
play a role in mediating the effect of rs17514846 on FURIN
expression. The findings of our study are consistent with the
accumulating evidence that intronic SNPs in many genes can
modulate gene expression.24,25
Second, our study demonstrates that the level of FURIN in
ECs exerts an effect on monocyte-endothelial adhesion and
transmigration. This finding is in line with, and extends on, our
previous observation that FURIN levels in monocytes influ-
ence monocytes’ migratory ability.6 There is evidence
suggesting that FURIN may regulate endothelin-1 activity by
cleaving intracellular pro–endothelin-1 and thereby facilitating
the secretion of active endothelin-1.26,27 In agreement, our
study shows that FURIN knockdown resulted in reduced
secretion of endothelin-1 but had no effect on cytoplasmic
endothelin-1 levels. Endothelin-1 has been found to induce
activation of NFjB,16,17 a transcription factor that regulates
the expression of genes associated with endothelial dysfunc-
tion and inflammation.28 In our study, NFjB activity and the
expression of VCAM1 and MCP1 in ECs were significantly
reduced after FURIN knockdown, indicating that FURIN can
influence endothelin-1 secretion, NFjB activity, and, in turn,
VCAM1 and MCP1 expression. This can explain the finding of
our study that FURIN knockdown inhibited monocyte-
endothelial adhesion and monocyte transendothelial migra-
tion, as it is well established that VCAM1 and MCP1 play key
roles in monocyte recruitment in atherogenesis.20 Further-
more, consistent with the notion that an alteration in FURIN
level can lead to a change in MCP1 expression, we found that
there was an association between rs17514846 and plasma
MCP1 levels in the Bruneck Study cohort, with the CAD risk
(A) allele associating with higher levels of MCP1. MCP1 levels
in individuals of the A/C genotype were similar to those in
individuals of the A/A genotype, suggesting that the A allele
might exert a dominant effect. Interestingly, the results of
Figure 6. Effects of FURIN knockdown endothelin-1 (ET1) secretion, nuclear factor (NF) jB activity, and MCP1 (monocyte chemotactic
protein-1) expression in vascular endothelial cells. FURIN siRNA-transfected endothelial cells at 72 hours after transfection were subjected to
Western blotting or ELISA. A, Western blot analysis of cellular ET1. A representative Western blot image is shown. ET1 band intensities were
normalized to b-actin band intensities. N=6 per group. B, ELISA analysis of secreted ET1 in cell culture supernatant. N=6 per group. C, ELISA
analysis of nuclear NFjB activity. N=10 per group. D, Western blot analysis of vascular cell adhesion molecule-1 (VCAM1). A representative
Western blot image is shown. VCAM1 band intensities were normalized to b-actin band intensities. N=9 per group. E, Western blot analysis of
MCP1. A representative Western blot image is shown. MCP1 band intensities were normalized to b-actin band intensities. N=7 per group.
A through E, Graphs show mean values normalized to untreated samples, and error bars show SE.
Table. Association Between rs17514846 Genotype and cIMT
Variable C/C (n=247) A/C (n=401) A/A (n=152) P Value
cIMT, mm 0.934 (0.013) 0.943 (0.010) 0.978 (0.017) 0.046
cIMT values shown are age- and sex-adjusted means (SEs). P value shown is for an
additive genetic model. cIMT indicates carotid artery intima-media thickness.
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measurement of FURIN expression level in ECs from different
individuals showed that the difference in FURIN expression
level in ECs between A/A and A/C genotypes was smaller
than that between the A/C and C/C genotype. Unlike the
finding for MCP1, we did not detect an association between
rs17514846 genotype and the level of circulating VCAM1,
intercellular adhesion molecule 1, E-selection, or P-selectin in
the Bruneck Study cohort. It is possible that this cohort did
not have sufficient statistical power for these tests because of
its moderate sample size.
Thus, the data we have obtained demonstrate that
rs17514846 genotype affects FURIN expression in ECs and
that altered FURIN level can influence VCAM1 and MCP1
expression and monocyte-endothelial adhesion and transmi-
gration. Furthermore, in a population-based cohort study, we
observed an association between the rs17514846 risk (A)
allele and greater carotid intima-media thickness, a well-
established biomarker of early atherosclerosis and a predictor
of future cardiovascular events.21,22 These findings provide an
insight into the biological mechanisms linking the 15q26.1
locus and CAD risk. They also indicate FURIN as a potential
therapeutic target for atherosclerosis. In support of this
notion, a recent study showed that FURIN inhibition reduces
atherosclerotic lesion progression in mice.5
Furthermore, the results of our study add to the accumu-
lating evidence indicating that FURIN plays important roles in
inflammation. In agreement with the findings reported herein
and in our recent study,6 Yakala et al demonstrated in a
mouse model that FURIN inhibitor treatment resulted in
decreased expression of inflammatory and cytokine genes in
vascular ECs and macrophages and reduced monocyte
migration.5 Furthermore, Kappert et al showed that FURIN
promotes adipose tissue–driven macrophage chemotaxis.29
On the other hand, Cordova et al reported that mice with
myeloid cell–specific deletion of FURIN displayed an
increased number of proinflammatory macrophages and
increased proinflammatory gene expression in their macro-
phages.30 It is possible that FURIN may play divergent roles in
inflammation in different situations, and further investigations
in this area would be warranted.
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